Immunohistochemical prognostic markers in bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Superficial bladder cancer management requires early recurrence detection and progression prevention.
• Current prognostic tools lack sufficient information beyond tumor size, grade, and multiplicity.
• Understanding molecular alterations is key to bladder cancer development and progression.

Purpose of the Study:

• To review promising immunohistochemical prognostic factors in bladder cancer.
• To highlight biomarkers involved in carcinogenesis, invasion, and metastasis.
• To aid in risk stratification for personalized treatment and follow-up.

Main Methods:

• Literature review of immunohistochemical prognostic factors.
• Analysis of molecular and genetic alterations in transitional-cell carcinoma (TCC).
• Examination of factors influencing tumor growth, cell cycle arrest, and apoptosis.

Main Results:

• Several immunohistochemical markers show potential for predicting bladder cancer behavior.
• Molecular changes, including oncogene mutations, drive TCC development.
• Tumor microenvironment interactions influence invasion and metastasis.

Conclusions:

• New prognostic biomarkers are essential for improved bladder cancer patient management.
• Risk stratification using these biomarkers can guide treatment and follow-up intensity.
• Further research into these factors can enhance understanding of bladder cancer progression.